New hope for kidney stone sufferers: drug and diet combo tested in major trial
NCT ID NCT06653738
First seen May 28, 2026 · Last updated Jun 18, 2026 · Updated 7 times
Summary
This study tests two approaches to prevent kidney stones from coming back in people who have had them before. One approach uses a daily pill called empagliflozin (a diabetes drug) and the other gives personalized diet advice based on urine tests. The trial will involve 400 adults with calcium-based kidney stones and will last 3 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY STONE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Charité University Medicine Berlin
Berlin, 10117, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Européen Georges Pompidou
Paris, 75908, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Tenon
Paris, 75020, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Inselspital Bern
Bern, 3010, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kantonsspital Aarau
Aarau, 5001, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kantonsspital Baden
Baden, 5404, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kantonsspital Chur
Chur, 7000, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kantonsspital Fribourg
Fribourg, 1708, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kantonsspital Luzern
Lucerne, 6016, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kantonsspital Neuchâtel
Neuchâtel, 2000, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kantonsspital Olten
Olten, 4600, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kantonsspital Sion
Sion, 1950, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kantonsspital St. Gallen
Sankt Gallen, 9007, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Lausanne University Hospital (CHUV)
Lausanne, 1011, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Regionalspital Lugano
Lugano, 6900, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Amiens-Picardie
Amiens, 80054, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Basel
Basel, 4031, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Geneva (HUG)
Geneva, 1211, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Università della Campania "Luigi Vanvitelli"
Naples, 80131, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitätsspital Zürich
Zurich, 8091, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Verona University Hospital
Verona, 37134, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.